|
⚲
|
| Keyboard |
| Septerna Inc | |
|---|---|
| Ticker | SEPN |
| CIK # | 0001984086 |
| CUSIP | 81734D104 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 250 East Grand Avenue, Suite 65, South San Francisco, CA 94080 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Septerna Inc | 2023-07-13 | 73.5 M | Exemption: 506(b) · Remaining: $76,500,001 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001984086] | 10-K | |
| [0001984086] | 10-Q | |
| [0001984086] | 3 | |
| [0001984086] | 4 | |
| [0001984086] | 8-K | |
| [0001984086] | D | |
| [0001984086] | SC 13D | |
| [0001984086] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Driehaus Capital Management LLC | Septerna Inc | [2025-02-14] | 0.0 |
| Third Rock Ventures V LP | Septerna Inc | [2025-02-13] | 0.0 |
| Samsara Biocapital LP | Septerna Inc | [2024-11-04] | 6.2 |
| RA Capital Management LP | Septerna Inc | [2024-11-04] | 15.8 |
| Biotechnology Value Fund L P | Septerna Inc | [2024-11-01] | 2.9 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Shaikhly Samira
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Option exercise | 53,714 | $0.00 | |
|
Shaikhly Samira
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Option exercise | 5,101 | $0.00 | |
|
Shaikhly Samira
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Option exercise | 11,638 | $0.00 | |
|
Shaikhly Samira
Common Stock
|
2026-03-02 | Sell | 4,090 | $27.51 | 112,516 |
|
Shaikhly Samira
Common Stock
|
2026-03-02 | Option exercise | 5,101 | $2.76 | 14,079 |
|
Shaikhly Samira
Common Stock
|
2026-03-02 | Sell | 66,363 | $28.14 | 1,867,455 |
|
Shaikhly Samira
Common Stock
|
2026-03-02 | Option exercise | 11,638 | $2.76 | 32,121 |
|
Shaikhly Samira
Common Stock
|
2026-03-02 | Option exercise | 53,714 | $1.55 | 83,257 |
|
Bhatt Elizabeth
Stock Option (Right to Buy) · derivative
|
2026-02-18 | Option exercise | 4,000 | $0.00 | |
|
Bhatt Elizabeth
Common Stock
|
2026-02-18 | Sell | 1,800 | $29.58 | 53,244 |
|
Bhatt Elizabeth
Common Stock
|
2026-02-18 | Sell | 2,200 | $28.46 | 62,612 |
|
Bhatt Elizabeth
Common Stock
|
2026-02-18 | Option exercise | 4,000 | $6.81 | 27,240 |
|
Bhatt Elizabeth
Stock Option (Right to Buy) · derivative
|
2026-02-06 | Grant | 155,000 | $0.00 | |
|
Long Daniel D
Stock Option (Right to Buy) · derivative
|
2026-02-06 | Grant | 80,000 | $0.00 | |
|
Klein Uwe
Stock Option (Right to Buy) · derivative
|
2026-02-06 | Grant | 80,000 | $0.00 | |
|
Shaikhly Samira
Stock Option (Right to Buy) · derivative
|
2026-02-06 | Grant | 80,000 | $0.00 | |
|
Labrucherie Gil M
Stock Option (Right to Buy) · derivative
|
2026-02-06 | Grant | 125,000 | $0.00 | |
|
Kim Jae B
Stock Option (Right to Buy) · derivative
|
2026-02-06 | Grant | 125,000 | $0.00 | |
|
Finer Jeffrey
Stock Option (Right to Buy) · derivative
|
2026-02-06 | Grant | 400,000 | $0.00 | |
|
Wilson Mark Andrew
Stock Option (Right to Buy) · derivative
|
2026-02-06 | Grant | 165,000 | $0.00 | |
| showing 20 of 74 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 125 | 45,986,954 |
| 2025-12-31 | 123 | 45,811,880 |
| 2025-09-30 | 85 | 45,322,952 |
| 2025-06-30 | 91 | 45,522,890 |
| 2025-03-31 | 74 | 45,392,878 |
| 2024-12-31 | 72 | 43,627,352 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Gamma Investing LLC | [2026-06-30] | DFND | 1,119 | 1,119 |
| Versant Capital Management Inc | [2026-06-30] | SOLE | 261 | 261 |
| MassMutual Private Wealth & Trust FSB | [2026-06-30] | SOLE | 104 | 104 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 20 | 20 | Prev | Page 1 | Next |